HPV (human papillomavirus) vaccination does not increase the risk of autoimmune disorders, finds a new study. The findings of the study are published in CMAJ (Canadian Medical Association Journal).
The study found no increased risk of autoimmune disorders in girls who received quadrivalent human papillomavirus (HPV4) vaccination, adding to the body of evidence for the safety of the vaccine.
Human Papillomavirus Infection
Human papillomavirus (HPV) infection, depending on the human papillomavirus that causes it, can result in common warts or can cause cervical cancer.
Advertisement
‘Human papillomavirus (HPV) is the most common sexually transmitted disease worldwide. HPV vaccination does not increase the risk of autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis.’
Tweet it Now
Human papillomavirus is the most common sexually transmitted disease worldwide, affecting 50%-75% of sexually active people. The HPV4 vaccine is effective at protecting against 90% of the strains that cause cervical and anal cancer. Despite studies showing the safety of the vaccine, there have been concerns about a possible link to autoimmune disorders.
"Despite demonstrated effectiveness in real-world settings, concerns continue to persist regarding the safety of the HPV4 vaccine. In light of these concerns, we wanted to study the HPV4 vaccination since it was being offered free to all grade 8 girls in Ontario through school-based clinics," says Dr. Jeffrey Kwong, a study author and a senior scientist at the Institute for Clinical Evaluative Sciences (ICES) and at Public Health Ontario.
![New HPV Vaccine Reduces The Risk Of HPV-Related Diseases]( "New HPV Vaccine Reduces The Risk Of HPV-Related Diseases")
A new improved Human papillomavirus (HPV) vaccine called 9vHPV has been developed greatly reduces the risk of HPV infection and HPV-related diseases.
To determine whether the HPV4 vaccination triggered autoimmune conditions such lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis, researchers looked at data on 290 939 girls aged 12 to 17 years in Ontario who were eligible for vaccination between 2007 and 2013. Of the total 180 819 girls who received the HPV4 (Gardasil and Merck) vaccination in school-based clinics, there were 681 diagnosed cases of autoimmune disorders between one week and two months after vaccination. This rate is consistent with the general rate of diagnosed cases in this age group.
"These findings add to the body of evidence on the safety of the HPV4 vaccine and should reassure parents and health care providers," says Dr. Linda Lévesque, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario.
Source: Eurekalert
New HPV Vaccine Reduces The Risk Of HPV-Related Diseases
A new improved Human papillomavirus (HPV) vaccine called 9vHPV has been developed greatly reduces the risk of HPV infection and HPV-related diseases.
Advertisement
To determine whether the HPV4 vaccination triggered autoimmune conditions such lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis, researchers looked at data on 290 939 girls aged 12 to 17 years in Ontario who were eligible for vaccination between 2007 and 2013. Of the total 180 819 girls who received the HPV4 (Gardasil and Merck) vaccination in school-based clinics, there were 681 diagnosed cases of autoimmune disorders between one week and two months after vaccination. This rate is consistent with the general rate of diagnosed cases in this age group.
"These findings add to the body of evidence on the safety of the HPV4 vaccine and should reassure parents and health care providers," says Dr. Linda Lévesque, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario.
Source: Eurekalert
HPV Vaccine to Prevent Cervical Cancer - New Insights
HPV vaccine - A safe and effective treatment in prevention of cervical cancer.
Advertisement
 Effectiveness of HPV Vaccination StudiedHuman papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.